Home › Funds › Artia Global Partners LP › VKTX

Artia Global Partners LP position in VKTX

VIKING THERAPEUTICS INC · Health Care

Artia Global Partners LP reported holding 180,731 shares of VKTX (VIKING THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$7.1M, representing 1.30% of its reported portfolio and ranking #17 among its reported holdings. Artia Global Partners LP has disclosed VKTX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)180.73K sh
Reported value held$7.05M
Portfolio Weight1.30%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Artia Global Partners LP's VKTX position evolved

Artia Global Partners LP first disclosed a stake in VKTX in Q3 2023 at 383,580 shares (US$4.2M). The position peaked in Q1 2024 at 433,580 shares, worth US$35.6M. Across 12 filings, Artia Global Partners LP increased the stake 5 time(s), trimmed it 3 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 180,731 shares valued at US$7.1M. Notable position changes include a 255% increase in Q3 2024 (shares fell 36% over the following quarter), a 83% trim in Q4 2024 (shares fell 40% over the following quarter), a 392% increase in Q4 2025 (shares fell 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 383.58K $4.25M New
Q4 2023 383.58K $7.14M Hold
Q1 2024 433.58K $35.55M Add
Q2 2024 150.00K $7.95M Reduce
Q3 2024 532.88K $33.74M Add
Q4 2024 90.28K $3.63M Reduce
Q1 2025 90.28K $2.18M Hold
Q2 2025 96.48K $2.56M Add
Q3 2025 146.18K $3.84M Add
Q4 2025 719.37K $25.31M Add
Q1 2026 180.73K $5.88M Reduce
Q2 2026 180.73K $7.05M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VKTX and 13F data

VKTX (VIKING THERAPEUTICS INC) is a Health Care company. 35 other funds we track also report a position in VKTX — the largest reported positions include Vestal Point Capital, LP (US$26.5M), Eversept Partners, LP (US$23.5M), ADAR1 Capital Management, LLC (US$22.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VKTX

All VKTX fund holders →

FAQ

How long has Artia Global Partners LP held VKTX?

Artia Global Partners LP has disclosed VKTX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Artia Global Partners LP's current position in VKTX?

As of Q2 2026, Artia Global Partners LP holds 180.73K shares of VKTX (VIKING THERAPEUTICS INC), valued at $7.05M, representing 1.30% of its reported portfolio and ranking #17.

Has Artia Global Partners LP been buying or selling VKTX?

In the latest 13F filing (Q2 2026), Artia Global Partners LP held unchanged its position in VKTX. The position peaked in Q1 2024 at 433.58K shares.

Which other funds hold VKTX?

Other major institutional holders of VKTX include Vestal Point Capital, LP, Eversept Partners, LP, ADAR1 Capital Management, LLC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.